Who invested in Obalon Therapeutics?
Obalon Therapeutics's investors include Square 1 Bank and AMOREPACIFIC Ventures.
United States · Series D startup
6 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$69Mraised across 6 rounds since 2012, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $16M sold, first sale Aug 2014
No investor was named in the report.
From a historical funding recordSEC filing: $16M sold, first sale Aug 2014
No investor was named in the report.
From a historical funding recordSEC filing: $16M sold, first sale Aug 2014
No investor was named in the report.
Reported by businesswire.comSEC filing: $17M sold, first sale May 2012
No investor was named in the report.
Reported by sec.govSEC filing: $1.5M sold, first sale Feb 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Obalon Therapeutics's investors include Square 1 Bank and AMOREPACIFIC Ventures.
Obalon Therapeutics has raised $69M across 6 rounds since 2012.
Obalon Therapeutics's most recent round was a Series D of $20M in Jan 2015.
Its most recent round, $20M in Jan 2015, is also its largest on record.
Obalon Therapeutics's first round on record, in Dec 2012, was backed by AMOREPACIFIC Ventures.
Obalon Therapeutics's latest named round is a Series D, in Jan 2015.
Obalon Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.